Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin.
D016360:Clostridioides difficile; D003428:Cross Infection / Q000382:microbiology*; D003967:Diarrhea / Q000382:microbiology*; D004359:Drug Therapy, Combination / Q000600:supply & distribution* / Q000627:therapeutic use*; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology*; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000600:supply & distribution* / Q000627:therapeutic use*; D010406:Penicillins / Q000600:supply & distribution* / Q000627:therapeutic use*; D010878:Piperacillin / Q000600:supply & distribution* / Q000627:therapeutic use*; D000078142:Tazobactam; D014481:United States
D010406:Penicillins; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin